AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Upon the achievement of certain milestones accelerating the warrants’ expiration date, AcelRx may receive an additional $16.3 million of gross proceeds if the common warrants are exercised in full HAYWARD, Calif., July 18, 2023 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX),…

Click here to view original post